Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem
نویسندگان
چکیده
M. Monaco1,2, T Giani2,3, M Raffone1,4, F Arena3, A Garcia-Fernandez1, S Pollini3, Network EuSCAPE-Italy5, H Grundmann6, A Pantosti ([email protected])1, G M Rossolini3,7,8 1. Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy 2. MM and TG have equally contributed to this work 3. Department of Medical Biotechnologies, University of Siena, Siena, Italy 4. Federico II University Hospital, Neaples, Italy 5. The network EuSCAPE-Italy participants are listed at the end of this article 6. Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands 7. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy 8. Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
منابع مشابه
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
Consecutive non-replicate clinical isolates (n=191) of carbapenem non-susceptible Enterobacteriaceae were collected from 21 hospital laboratories across Italy from November 2013 to April 2014 as part of the European Survey on Carbapenemase-producing Enterobacteriaceae (EuSCAPE) project. Klebsiella pneumonia carbapenemase-producing K. pneumoniae (KPC-KP) represented 178 (93%) isolates with 76 (4...
متن کاملKPC-producing Klebsiella pneumoniae, finally targeting Turkey
We report here the first identification of the worldwide spread of Klebsiella pneumoniae carbapenemase-2-producing and carbapenem-resistant K. pneumoniae clone ST258 in Turkey, a country where the distantly-related carbapenemase OXA-48 is known to be endemic. Worryingly, this isolate was also resistant to colistin, now considered to be the last-resort antibiotic for carbapenem-resistant isolates.
متن کاملContainment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
In 2010 the Hellenic center for disease control and prevention launched the "Prokroustes" nationwide action plan to tackle the increasing rates of carbapenem resistance among gram-negative nosocomial pathogens. In the present report, data from a Greek tertiary-care hospital are presented three years after the adoption of the infection control measures. Carbapenem resistance rates have been cont...
متن کاملشناسایی ایزوله های کلبسیلا پنومونیه دارای ژن blaCTX و تعیین مقاومت متقاطع آنها در بیماران بستری در بیمارستان
Background and Aim: Klebsiella pneumoniae is a member of the Enterobacteriaceae family. There is a global emergence of multidrug-resistant (MDR) strains of K. pneumoniae, a Gram-negative enteric bacterium that causes nosocomial and urinary tract infections. The aims of the present study were to identify the Klebsiella pneumoniae infections in hospitalized patients, characterization of blaCTX ge...
متن کاملMolecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae Causing Bacteremia from India—A First Report
Colistin has long been a reserve drug used for the treatment of carbapenem resistant Klebsiella pneumoniae. Carbapenem resistance in K. pneumoniae has been increasing and is as high as 44% in India. Although a reserve agent, with rise in rates of resistance to carbapenems, the usage of colistin has increased over the years leading to slow emergence of resistance. Colistin resistance is mainly m...
متن کامل